These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin. Guerra E; Lattanzio R; La Sorda R; Dini F; Tiboni GM; Piantelli M; Alberti S PLoS One; 2012; 7(11):e49302. PubMed ID: 23209569 [TBL] [Abstract][Full Text] [Related]
9. Frequency of rearrangements in Lynch syndrome cases associated with MSH2: characterization of a new deletion involving both EPCAM and the 5' part of MSH2. Pérez-Cabornero L; Infante Sanz M; Velasco Sampedro E; Lastra Aras E; Acedo Becares A; Miner Pino C; Durán Domínguez M Cancer Prev Res (Phila); 2011 Oct; 4(10):1556-62. PubMed ID: 21791569 [TBL] [Abstract][Full Text] [Related]
10. Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction. Kozan PA; McGeough MD; Peña CA; Mueller JL; Barrett KE; Marchelletta RR; Sivagnanam M J Mol Med (Berl); 2015 May; 93(5):535-45. PubMed ID: 25482158 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of Italian patients with congenital tufting enteropathy. d'Apolito M; Pisanelli D; Faletra F; Giardino I; Gigante M; Pettoello-Mantovani M; Goulet O; Gasparini P; Campanozzi A World J Pediatr; 2016 May; 12(2):219-24. PubMed ID: 26684320 [TBL] [Abstract][Full Text] [Related]
12. Identification of a founder EPCAM deletion in Spanish Lynch syndrome families. Mur P; Pineda M; Romero A; Del Valle J; Borràs E; Canal A; Navarro M; Brunet J; Rueda D; Ramón Y Cajal T; Lázaro C; Caldés T; Blanco I; Soto JL; Capellá G Clin Genet; 2014 Mar; 85(3):260-6. PubMed ID: 23530899 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of intestinal biopsies for pediatric enteropathy: a proposed immunohistochemical panel approach. Martin BA; Kerner JA; Hazard FK; Longacre TA Am J Surg Pathol; 2014 Oct; 38(10):1387-95. PubMed ID: 25188866 [TBL] [Abstract][Full Text] [Related]
14. Tufting enteropathy and chronic arthritis: a newly recognized association with a novel EpCAM gene mutation. Al-Mayouf SM; Alswaied N; Alkuraya FS; Almehaidib A; Faqih M J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):642-4. PubMed ID: 19820410 [No Abstract] [Full Text] [Related]
16. Further evidence for EpCAM as the gene for congenital tufting enteropathy. Sivagnanam M; Schaible T; Szigeti R; Byrd RH; Finegold MJ; Ranganathan S; Gopalakrishna GS; Tatevian N; Kellermayer R Am J Med Genet A; 2010 Jan; 152A(1):222-4. PubMed ID: 20034091 [No Abstract] [Full Text] [Related]
17. Four mutations (three novel, one founder) in TACSTD2 among Iranian GDLD patients. Alavi A; Elahi E; Tehrani MH; Amoli FA; Javadi MA; Rafati N; Chiani M; Banihosseini SS; Bayat B; Kalhor R; Amini SS Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4490-7. PubMed ID: 17898270 [TBL] [Abstract][Full Text] [Related]
18. Enteroids expressing a disease-associated mutant of EpCAM are a model for congenital tufting enteropathy. Das B; Okamoto K; Rabalais J; Kozan PA; Marchelletta RR; McGeough MD; Durali N; Go M; Barrett KE; Das S; Sivagnanam M Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G580-G591. PubMed ID: 31433211 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification. Musulen E; Blanco I; Carrato C; Fernandez-Figueras MT; Pineda M; Capella G; Ariza A Hum Pathol; 2013 Mar; 44(3):412-6. PubMed ID: 23026194 [TBL] [Abstract][Full Text] [Related]
20. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Kovacs ME; Papp J; Szentirmay Z; Otto S; Olah E Hum Mutat; 2009 Feb; 30(2):197-203. PubMed ID: 19177550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]